Physician

James Benjamin Kay, M.D.

According to 2025 Medicare claims, James Kay, M.D. (NPI: 1679795017) practices urology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Burke, GA. This provider's primary affiliated billing organization is AUGUSTA UROLOGY ASSOCIATES, LLC (NPI: 1366511834; TIN: 58-2314108) and primary practice location at 30809-3346. Kay is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Kay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,339 traditional Medicare patients, billed 13,566 HCPCS/CPT codes, and received $467,970 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,816 prescription claims across 922 beneficiaries totaling $1,320,350 in drug costs, led by Nubeqa (Darolutamide). DME data shows 32 claims. Open Payments data shows 30 records totaling $1,235. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $207,882 to $467,970. Similarly, Part D prescription costs have moved sharply higher in recent years, from $100,963 to $1,320,350. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $280 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	762	8,427	$207,882
2016	857	8,609	$218,643
2017	999	10,034	$240,617
2018	1,109	10,513	$292,061
2019	1,169	8,836	$279,920
2020	1,150	9,063	$245,733
2021	1,116	9,914	$263,346
2022	1,105	11,497	$281,723
2023	1,128	11,202	$269,450
2024	1,339	13,566	$467,970

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	323	1,383	$100,963
2016	379	1,531	$137,181
2017	431	1,634	$166,267
2018	473	1,740	$161,900
2019	535	1,936	$181,656
2020	512	1,748	$229,103
2021	515	1,709	$208,339
2022	576	1,829	$298,730
2023	649	1,997	$506,545
2024	922	2,816	$1,320,350

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	65	$21,579
2016	N/R	60	$14,561
2017	N/R	50	$10,338
2018	N/R	41	$3,236
2019	N/R	29	$6,423
2020	N/R	52	$9,293
2021	N/R	39	$7,156
2022	N/R	42	$32,047
2023	N/R	38	$30,818
2024	N/R	32	$17,696

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,044	1,507	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	221	266	$12
36415	Insertion of needle into vein for collection of blood sample	231	291	$9
51798	Ultrasound measurement of bladder capacity after voiding	339	482	$7
81003	Automated urinalysis test	695	995	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nubeqa	Darolutamide	46	1,380	$615,275
Orgovyx	Relugolix	108	3,258	$277,977
Myrbetriq	Mirabegron	177	8,954	$130,920
Gemtesa	Vibegron	208	7,407	$117,418
Tamsulosin Hcl	Tamsulosin Hcl	915	65,705	$12,636

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	15	$11,352
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	17	$6,344

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$1,235	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Benjamin Kay, M.D.?

Tedicare shows public-source Medicare data for James Benjamin Kay, M.D. (NPI 1679795017), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Benjamin Kay, M.D. have ACO affiliation data?

James Benjamin Kay, M.D. is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to James Benjamin Kay, M.D.?

James Benjamin Kay, M.D. is linked to AUGUSTA UROLOGY ASSOCIATES, LLC (billing NPI 1366511834) in the available physician profile data.

Does James Benjamin Kay, M.D. have Open Payments data?

James Benjamin Kay, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.